Clinical Trials
2,612 trialsStudy of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)
National Institutes of Health Clinical Center (CC)
Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
National Institutes of Health Clinical Center (CC)
DoDNAC
Children's Hospital Medical Center, Cincinnati
ADDICT-pedGLIO
University Hospital, Antwerp
Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas
OHSU Knight Cancer Institute
Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma
Case Comprehensive Cancer Center
PROMESSE
Institut du Cancer de Montpellier - Val d'Aurelle
GLOW
UMC Utrecht
Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
National Cancer Institute (NCI)
Fast MRI
Karolinska University Hospital
Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM
Northwell Health
Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors
National Institutes of Health Clinical Center (CC)
Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1
National Institutes of Health Clinical Center (CC)
Rare CNS Tumors Outcomes &Risk
National Institutes of Health Clinical Center (CC)
Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma
Cantex Pharmaceuticals
SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors
Sarcoma Alliance for Research through Collaboration
Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma
University of California, San Francisco
NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
CRANIOEXE
University Hospital, Bordeaux
Multimodal Machine Learning Characterization of Solid Tumors
Massachusetts General Hospital
REVEAL
Ono Pharmaceutical Co., Ltd.
Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases
National Institutes of Health Clinical Center (CC)
MEN-301
NX Development Corp
[18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes
Telix Pharmaceuticals (Innovations) Pty Limited
MISOGLIO
University Hospital, Bordeaux
Study of Pamiparib in Newly Diagnosed and rGBM
St. Joseph's Hospital and Medical Center, Phoenix
Radiosurgery Before Surgery for the Treatment of Brain Metastases
Emory University
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy
M.D. Anderson Cancer Center
BEACON
University of Birmingham
A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Recurrent Meningioma
Heron Neutron Medical Corp.
Hypofractionated Stereotactic Radiosurgery in Treating Patients With Large Brain Metastasis
Emory University
TEMOBIC
Assistance Publique Hopitaux De Marseille
Development and Implementation of an Intervention Enhancing Involvement of Relatives to Patients With Acquired Brain Injury or Malignant Brain Tumour
Rigshospitalet, Denmark
LEAP-005
Merck Sharp & Dohme LLC
TUXEDO-3
MedSIR
PPROSPERITIT
Masaryk University
NEUROBLU 02
Institut Claudius Regaud
Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
Mayo Clinic
N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
Utility of Perfusion MRI to Detect Radiation Necrosis in Patients With Brain Metastases
Emory University
Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy
Children's Oncology Group
IMOTEP
Centre Antoine Lacassagne
POSEIDON
Centre Antoine Lacassagne
METAPERF
University Hospital, Lille
Chronic Convection Enhanced Delivery of Topotecan
Columbia University
PROTONBIOMARKS
Centre Leon Berard
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
NF1NAC
Children's Hospital Medical Center, Cincinnati
FCI in Post-operative Low Grade Gliomas
NHS Grampian
Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
National Institutes of Health Clinical Center (CC)